Learning Objectives:
1. Defining TNBC and the Prior Treatment Strategies
2. Current Treatment Agents in Early-Stage TNBC
3. Future Therapeutics and Clinical Trials Presently For Early-Stage TNBC
Session date:
10/24/2024 - 8:00am to 9:00am CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Ashley Hardeman, MD